Augmedix, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Common Stock, Preferred Stock and Convertible Preferred Stock (Tables)

Common Stock, Preferred Stock and Convertible Preferred Stock (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2021

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of warrants outstanding to acquire shares of its common stock

Expiration Date		Shares of common stock issuance upon exercise of warrants		Exercise Price Per Warrant
June 11, 2025		234		$	96.24
November 13, 2025		218,078		$	3.00
July 28, 2027		91		$	106.17
August 28, 2028		1,052		$	39.76
September 2, 2029		2,767,836		$	2.88
Earlier of March 24, 2031 and the third anniversary of the Company’s listing on Nasdaq		346,500		$	3.00
		3,333,791

Expiration Date		Shares of common stock issuance upon exercise of warrants		Exercise Price Per Warrant
August 7, 2024		4,208		$	0.86
June 11, 2025		234		$	96.24
November 13, 2025		218,078		$	3.00
July 28, 2027		91		$	106.17
August 28, 2028		1,052		$	39.76
September 2, 2029		2,767,836		$	2.88
		2,991,499

Schedule of convertible preferred stock shares outstanding

		Shares Issued and Outstanding
Series A		2,683,500
Series A-1		5,367,001
Series B		6,588,542
		14,693,043